Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy GH Research PLC Ordinary Shares stock

Learn how to easily invest in GH Research PLC Ordinary Shares stock.

GH Research PLC Ordinary Shares is a biotechnology business based in the US. GH Research PLC Ordinary Shares shares (GHRS) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in GH Research PLC Ordinary Shares

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GHRS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

GH Research PLC Ordinary Shares stock price (NASDAQ: GHRS)

Use our graph to track the performance of GHRS stocks over time.

GH Research PLC Ordinary Shares shares at a glance

Information last updated 2022-01-12.
Latest market close$19.21
52-week range$12.38 - $30.43
50-day moving average $23.59
200-day moving average $21.13
Wall St. target price$40.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.14

Buy GH Research PLC Ordinary Shares shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy GH Research PLC Ordinary Shares stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

GH Research PLC Ordinary Shares price performance over time

Historical closes compared with the close of $19.21 from 2022-01-14

1 week (2022-01-07) 2.84%
1 month (2021-12-16) -24.61%
3 months (2021-10-15) 13.00%
6 months (2021-07-16) 9.77%
1 year (2021-01-12) N/A
2 years (2020-01-12) N/A
3 years (2019-01-12) N/A
5 years (2017-01-12) N/A

GH Research PLC Ordinary Shares financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $5.45
Market capitalisation $997.8 million

TTM: trailing 12 months

GH Research PLC Ordinary Shares share dividends

We're not expecting GH Research PLC Ordinary Shares to pay a dividend over the next 12 months.

You may also wish to consider:

GH Research PLC Ordinary Shares overview

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that is being investigated in the Phase 2 part of an ongoing Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate that is in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was founded in 2018 and is based in Dublin, Ireland. .

Frequently asked questions

What percentage of GH Research PLC Ordinary Shares is owned by insiders or institutions?
Currently 41.318% of GH Research PLC Ordinary Shares shares are held by insiders and 55.093% by institutions.
When does the fiscal year end for GH Research PLC Ordinary Shares?
GH Research PLC Ordinary Shares's fiscal year ends in December.
Where is GH Research PLC Ordinary Shares based?
GH Research PLC Ordinary Shares's address is: 28 Baggot Street Lower, Dublin, Ireland, D02 NX43
What is GH Research PLC Ordinary Shares's ISIN number?
GH Research PLC Ordinary Shares's international securities identification number is: IE000GID8VI0

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site